Peritoneal Cancer - Pipeline Insight, 2021

SKU ID : DEL-19306978 | Publishing Date : 12-Oct-2021 | No. of pages : 60

Detailed TOC of Peritoneal Cancer - Pipeline Insight, 2021

Introduction
Executive Summary
Peritoneal cancer: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Late Stage Products (Phase III)
• Comparative Analysis
Mirvetuximab soravtansine: ImmunoGen
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
PF-06873600: Pfizer
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Early stage products (Phase I/II)
• Comparative Analysis
ART0380: Artios Pharma
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Peritoneal cancer Key Companies
Peritoneal cancer Key Products
Peritoneal cancer- Unmet Needs
Peritoneal cancer- Market Drivers and Barriers
Peritoneal cancer- Future Perspectives and Conclusion
Peritoneal cancer Analyst Views
Peritoneal cancer Key Companies
Appendix

List of Figures, Tables and Charts Available in Peritoneal Cancer - Pipeline Insight, 2021

Table 1 Total Products for Peritoneal cancer
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

Keyplayers in Peritoneal Cancer - Pipeline Insight, 2021

• Pfizer
• ImmunoGen
• Boryung Pharmaceutical
• OncoQuest
• Janssen Research & Development
• OncXerna Theraputics
• Merck & Co
• Sotio a.s.
• AstraZeneca
• Lee's Pharmaceutical
• Corcept Therapeutics
• GlaxoSmithKline
• Pfizer
• Bristol-Myers Squibb
• Seagen Inc.
• CSPC ZhongQi Pharmaceutical Technology
• Context Therapeutics
• Medivation, Inc.
• Astex Pharmaceuticals
• APIM Therapeutics
• Celsion
• Syndax Pharmaceuticals
• ImmunoVaccine Technologies
• Regeneron Pharmaceuticals
• Mucpharm Pty Ltd
• Artios Pharma
• Sumitomo Dainippon Pharma
• OncoQuest Pharma
• Genelux Corporation
• Y-mAbs Therapeutics
• PGEN Therapeutics
• Jiangsu HengRui Medicine